![Jemma Arakelyan: I have been ranked in the top 5% of PG researchers and have received Excellent Paper Awards](https://oncodaily.com/pub/uploads/2023/09/Jemma-Arakelyan-e1693859071448-1280x968.jpeg)
Jemma Arakelyan: I have been ranked in the top 5% of PG researchers and have received Excellent Paper Awards
Jemma Arakelyan, CEO of the Institute of Cancer and Crisis, shared on LinkedIn:
“Delighted to share that for the second consecutive year, I have been ranked in the top 5% of PG researchers and have received Excellent Paper Awards in 2022/23 and 2023/24!
I extend my sincere appreciation to my dear supervisor Dr. Maria Babak and the entire research team for their dedication and collaborative efforts.
I am truly grateful to have had the honor of Prof Raymond Chan (Dean of CSCI) and Associate Dean Prof Daniel Ho presenting the awards. ”
Source: Jemma Arakelyan / LinkedIn
Jemma Arakelyan, MD is the CEO of the Institute of Cancer and Crisis (ICC), an Adjunct Assistant Professor at the Department of Hematology and Pediatric Oncology of the Yerevan State Medical University (YSMU), Adviser and Medical Oncologist at the Immune Oncology Research Institute (IMMONC) and a PhD program candidate at the Department of Chemistry of the City University of Hong Kong. She is an Editorial Board Member of OncoDaily.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023